05.23.24 -- A Good Feeling ($$) About Contract Manufacturing

Join us on May 28th with Lonza to learn about the challenges that drug developers face in the early space. We’ll identify the pitfalls of suboptimal risk assessment and review an integrated approach to design and de-risking of early development candidates to streamline the path to GMP. Click here to learn more.

You can't improve what you don't measure. This discussion explores advances in cell counting technology and the number of ways it aids the biotech industry and beyond.

Delve into the exciting potential of OVs, including the role of cell and virus seed banks, and discover key considerations for establishing cell and virus banks for OV production.

Producing mRNA therapeutics requires navigating complex manufacturing challenges. A strategic partnership with an integrated CMO streamlines manufacturing processes and reduces costs.

Examine the drivers behind the recent successes in the clinic, current challenges with development and manufacturing, and what the future might hold for the ADC industry.

Explore some of the more challenging aspects surrounding in-use testing for parenteral delivery along with potential strategies to address these issues.

Determining ideal media composition for a bacteria is critical because it fosters a satisfactory grow rate, allowing the bacteria to reach the required growth yield.

Understanding the Fc region of your antibody is crucial for assessing the impact on immunology, safety, and efficacy. Explore the most efficient ways to test functionality.

Delivering high viscosity (HV) formulations with a truly human solution involves a balance between safety and practicality. Learn the importance of achieving this solution with HV autoinjector design.

Three studies cover a product that aims to address unmet needs around the development of subcutaneous drug therapies for chronic disease treatment, including methods for sterilization and a Human Factors evaluation.

Choosing the right host is key to creating scalable, robust, and reliable commercial processes. Explore common challenges associated with the insect cell culture/baculovirus expression vector systems platform.

PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.

LabZient presents a breakthrough in analytical development for complex biologics, offering a cost-effective, efficient, and scientifically sound path to clinical trial readiness.

An affinity chromatography resin for purifying recombinant proteins using the self-cleaving Cytiva Protein Select tag.

Leveraging robust analytical services at every stage of development and manufacturing is crucial to ensure your therapy reaches patients in need on time and within budget.